Clinical Trials in Florida

Showing 5921-5940 of 12,796 trials

Facilitating Smoking Cessation With Reduced Nicotine Cigarettes

NCT02796391

STUDY 1: INTERVENTION DEVELOPMENT The purpose of this study is to determine the best way to help people stop smoking by using very low nicotine content (VLNC) cigarettes. This developmental pilot study (n=20) will determine the feasibility of the treatment approach and methodology using a targeted intervention, and lead to refinements for a subsequent randomized controlled trial (RCT). STUDY 2: RANDOMIZED CONTROLLED TRIAL The purpose of this study is to see if a targeted intervention will help people to stop or reduce smoking better than a standard intervention using very low nicotine content (VLNC) cigarettes, and to determine the optimal nicotine tapering schedule (gradual vs. immediate) during a 5-week pre-quit period. About 208 participants will take part in this phase of the study at Moffitt Cancer Center.

Smoking Cessation

H. Lee Moffitt Cancer Center and Research Institute163 participantsStarted Sep 2017

Tampa, Florida, United States

WITHDRAWNPhase 349 miles

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

NCT05233410

The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adult participants with diagnosis of chronic hand eczema (CHE) and moderate to severe disease activity (Investigator's Global Assessement (IGA) of CHE score 3 or 4).

Chronic Hand Eczema (CHE)

Incyte CorporationStarted Jan 2023

Birmingham, Alabama, United States • Huntington Beach, California, United States • Westminster, California, United States +36 more locations

Facilitating Smoking Cessation With Reduced Nicotine Cigarettes

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

Find Trials by Condition in Florida

Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks

RED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure Trial

Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease

Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia

Using Bluetooth Home Blood Pressure Monitors With Pharmacist Interventions

Optimal Metabolic Health Through Continuous Glucose Monitoring

A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma

LDL-C Assessment With PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2

Long-Term Study of Hydrocodone Bitartrate Controlled-release Capsules in Subjects With Chronic Pain

Phase 3 Study With Carfilzomib and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed Multiple Myeloma Patients

Monoclonal Antibody Against PCSK9 to Reduce Elevated Low-density Lipoprotein Cholesterol (LDL-C) in Adults Currently Not Receiving Drug Therapy for Easing Lipid Levels

A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients

Predictive Assay for Decision Making in Adjuvant Therapy

A Study of Polatuzumab Vedotin (DCDS4501A) in Combination With Rituximab or Obinutuzumab Plus Bendamustine in Participants With Relapsed or Refractory Follicular or Diffuse Large B-Cell Lymphoma

Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects

A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients

A Study to Investigate CSL312 in Subjects With Hereditary Angioedema (HAE)